Xencor, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
XNCR Nasdaq 2830 www.xencor.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Xencor, Inc.

How Investors May Respond To Xencor (XNCR) Narrowing Quarterly Losses Amid Deeper First‑Half Deficit - Aug 8th, 2026 6:12 am
Xencor (XNCR) Reports Q2 Loss, Beats Revenue Estimates - Aug 5th, 2026 3:25 pm
Xencor Reports Second Quarter 2026 Financial Results - Aug 5th, 2026 2:01 pm
Sector Update: Healthcare Stocks Decline Late Afternoon - Jul 30th, 2026 1:46 pm
Xencor to Receive $105 Million From Alexion to Resolve Ultomiris® U.S. Royalty Matter - Jul 29th, 2026 2:01 pm
Xencor (XNCR) Soars 16.9%: Is Further Upside Left in the Stock? - Jul 20th, 2026 5:26 am
Xencor Announces Proffered Paper Oral Presentation at ESMO 2026 for Phase 1 Clinical Study of XmAb819 in Advanced Clear Cell Renal Cell Carcinoma - Jul 17th, 2026 7:11 am
VERAXA Biotech Stock in Focus as Lead Cancer Program Reaches Development Milestone - Jul 2nd, 2026 4:40 pm
Xencor (XNCR) Stock Draws Fresh Price Target Split As Pipeline Progress Meets Caution - Jun 13th, 2026 11:11 pm